Geron Corporation
Tracked across 1 events · 6 articles · First seen Mar 13, 2025 · Last active May 25, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Geron Corporation announced positive real-world evidence study results for its drug RYTELO (imetelstat) in lower-risk myelodysplastic syndromes (LR-MDS), which supports its continued use and potential for expanded treatment options.
May 12, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Geron Corporation live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard